Cowen Initiates Coverage of Top Booze and Beer Stocks
In an initiation of the spirits and beer segment, the analysts at Cowen telegraphed their love of whiskey and craft beers.
In an initiation of the spirits and beer segment, the analysts at Cowen telegraphed their love of whiskey and craft beers.
A new research report from Deutsche Bank makes the case that the demise of RadioShack could prove to be a positive for electronics retailer Best Buy.
If any specific industry has become the poster child for volatility, it is the clean technology sector.
A new research report from UBS focuses on four top companies that are making great strides in treatments for patients -- and generating gigantic revenues.
All stock market indexes rebalance on a quarterly basis, as price movement constantly upsets the actual percentage that is supposed to be allocated.
When you have had a market rally like we have experienced the past two years, there comes a time when stock rotation becomes important.
With the summer doldrums over, the stock market is starting to return to normal. We also saw some very large insider selling in a top European pharmaceutical stock.
Insiders looking to buy stock took advantage of the better volumes and returned to the market this past week.
In their Triple Play selections, the Oppenheimer team combines three specific criteria when picking stocks. Three top new stocks to buy have made the list.
The analysts at Cowen have initiated coverage of clean technology with top stocks to buy in all four of its subsectors.
A new report from the Internet team at Jefferies focuses primarily on August sales numbers and traffic, and it is very clear that the dominant Internet companies continue to get stronger.
A new report from RBC handicaps just who look to be the biggest winners as Apple takes another step forward into a new arena.
Cowen offers tech investors two solid ways to participate in this fast-growing data networking arena: two tried and true tech names and two up-and-comers.
While not flashy or super high-profile, these health care companies are expected to deliver solid earnings growth for the foreseeable future.
A new research report from the Dividend Ruler Stocks team at UBS indicates that stocks on their list have increased dividends by an average of 11% thus far in 2014.
A new report from RBC highlights the fact that while gold's spot price has remained range-bound and tepid, some of the top producers are up far more this year than the S&P 500 is.
A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy for the rest of this year and 2015, and the analysts keep the answers…
A new report from the energy research team at UBS points out that there has been little merger and acquisition activity in the energy sector.
SunTrust Robinson Humphrey opens up coverage of the biotech sector with four top biotech stocks to buy and one Neutral-rated stock.
With less than one-third of the year remaining, many portfolio managers are looking for some outperformance so they can catch up to whatever benchmark they are chasing.